About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Houston | 825 Studies

Clinical Trials Lung CancerHouston

Lung Cancer Clinical Trials in Houston

Find 825 clinical trials for lung cancer near Houston, Texas. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 521-540 of 825 trials

CompletedStudy of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumThe purpose of this study is to determine the potential of denosumab to treat Hypercalcemia of Malignancy in patients with elevated serum calcium who do not respond to recent…NCT00896454·Encinitas, California and 23 others Active not recruitingTaletrectinib Phase 2 Global Study in ROS1 Positive NSCLCThe main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of advanced NSCLC.NCT04919811·Beverly Hills, California and 76 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedAdagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)This study will evaluate safety, tolerability, drug levels, molecular effects and clinical activity of MRTX849 (adagrasib) in combination with BI 1701963 in patients with advanced…NCT04975256·St Louis, Missouri and 3 others

CompletedPhase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung CancerThe purpose of this study is to determine the effectiveness and safety of TLK286 given intravenously once every three weeks in combination with docetaxel (Taxotere) in the…NCT00047801·Los Angeles, California and 3 others

Active not recruitingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)A Phase I-II, First-in-Human Study of SKB264 (Sac-TMT; MK-2870) in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard…NCT04152499·Glendale, California and 108 others

RecruitingSMP-3124LP in Adults With Advanced Solid TumorsAn Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid…NCT06526819·Los Angeles, California and 12 others

TerminatedFT516 in Combination With Monoclonal Antibodies in Advanced Solid TumorsThis is a Phase 1 dose-finding study of FT-516 in combination with monoclonal antibodies in participants with advanced solid tumors.NCT04551885·Minneapolis, Minnesota and 2 others

RecruitingA Study of IBI363 in Subjects with Advanced Solid MalignanciesThis is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in subjects with advanced, refractory solid…NCT06281678·San Francisco, California and 8 others

RecruitingA Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation…NCT06667908·La Jolla, California and 43 others

CompletedThe Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck CancerThis study is to examine the effects on tumors of AZD2171, in the treatment of NSCLC or HNC. The safety and tolerability of AZD2171 will also be studied.NCT00243347·Houston, Texas and 1 other

Active not recruitingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments.NCT03401385·Los Angeles, California and 17 others

CompletedOsimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung CancerThis phase Ib trial studies the best dose, safety, and effect of alisertib or sapanisertib, in combination with osimertinib, in treating patients with EGFR mutated stage IIIB or…NCT04479306·Houston, Texas

RecruitingA Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsThe main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants alone or in combination with other anticancer…NCT06561685·Santa Monica, California and 32 others

CompletedAn Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerThe purpose of this study is to evaluate the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell…NCT02917993·La Jolla, California and 30 others

CompletedA Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsThis is an open-label, Phase I, dose-escalation study to determine the recommended Phase 2 dose (RPTD), maximum tolerated dose (MTD), and evaluate the safety and pharmacokinetic…NCT02955251·Scottsdale, Arizona and 14 others

CompletedS0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00026156·Mobile, Alabama and 95 others

Active not recruitingPhase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerThis study will assess safety, tolerability, and treatment activity of datopotamab deruxtecan (Dato-DXd) in combination with immunotherapy with or without carboplatin in…NCT04612751·La Jolla, California and 41 others

TerminatedA Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies.NCT06704724·Fayetteville, Arkansas and 12 others

CompletedRadiation Therapy in Treating Patients With Stage I Non-Small Cell Lung CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00960999·Auburn, California and 37 others

TerminatedA Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) PopulationThis is a Phase II, randomized, open-label, multi-center study in advanced (Stage IVA and IVB subjects per the International Association for the Study of Lung Cancer (IASLC) 2009…NCT01313663·Tucson, Arizona and 24 others

PreviousPage 27 of 42Next

Other Conditions in Houston

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma